Market cap
$92 Mln
Revenue (TTM)
$68 Mln
P/E Ratio
1
P/B Ratio
0.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 16.71 | 14.04 | 15.46 | 2.95 | 5.39 |
| EBIT | -98.37 | 124.80 | 294.63 | 39.98 | 30.27 |
| Net Profit | -100.56 | -101.10 | 39.43 | 63.26 | -12.31 |
| EPS | -100.44 | -102.44 | 437.11 | 30.02 | 19.73 |
| Book Value | -- | -- | 24.16 | -41.33 | -40.60 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -131.95 | -177.25 | 226.10 | -39.24 | -188.91 |
| Net Margin
| -- | -69.59 | 163.32 | -- | -- |
| Return on equity
| -124.37 | -110.03 | 78.04 | 18.77 | -203.16 |
| Return on Capital
| -27.49 | -33.25 | -- | 6.12 | -44.68 |
| Return on Assets
| -17.21 | -18.89 | 28.68 | 4.13 | -29.51 |
| Debt to Equity (x)
| -- | -- | 0.00 | 1.49 | 3.34 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
--
|
6.12
|
-44.68
|
-43.90
|
-49.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
78.04
Higher than Peers by 59.07
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
78.04
|
18.77
|
-203.16
|
-188.71
|
-115.13
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
ROA
28.68
Higher than Peers by 25.83
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
28.68
|
4.13
|
-29.51
|
-26.26
|
-25.06
|
|
Peer Median
|
2.86
|
--
|
--
|
--
|
--
|
EBIT Margin
226.10
Higher than Peers by 210.28
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
226.10
|
-39.24
|
-188.91
|
-167.69
|
-268.07
|
|
Peer Median
|
15.82
|
--
|
--
|
--
|
--
|
Net Margin
163.32
Higher than Peers by 155.09
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
163.32
|
10.77
|
-79.75
|
-71.75
|
-114.30
|
|
Peer Median
|
8.23
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
15.46
Higher than Peers by 7.40
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
15.46
|
0.10
|
-0.32
|
0.12
|
0.10
|
|
Peer Median
|
8.05
|
--
|
--
|
--
|
--
|
EBIT Growth
294.63
Higher than Peers by 286.37
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
294.63
|
77.21
|
23.12
|
30.20
|
-32.75
|
|
Peer Median
|
8.26
|
--
|
--
|
--
|
--
|
Net Profit Growth
39.43
Higher than Peers by 31.70
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
39.43
|
114.82
|
24.14
|
29.96
|
-33.80
|
|
Peer Median
|
7.73
|
--
|
--
|
--
|
--
|
EPS Growth
437.11
Higher than Peers by 426.71
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
437.11
|
1.08
|
0.71
|
0.46
|
-0.23
|
|
Peer Median
|
10.39
|
--
|
--
|
--
|
--
|
Book Value Growth
201.12
Higher than Peers by 196.25
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
201.12
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4.87
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
--
|
1.49
|
3.34
|
3.76
|
3.05
|
|
Peer Median
|
0.59
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.04
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
0.04
|
0.04
|
0.14
|
0.24
|
0.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
3.96
Higher than Peers by 2.31
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
3.96
|
2.49
|
1.27
|
1.38
|
1.80
|
|
Peer Median
|
1.65
|
--
|
--
|
--
|
--
|
Quick Ratio
3.83
Higher than Peers by 2.63
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
3.83
|
2.30
|
1.06
|
1.26
|
1.69
|
|
Peer Median
|
1.20
|
--
|
--
|
--
|
--
|
Interest Coverage
17.26
Higher than Peers by 12.49
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
17.26
|
-2.85
|
-10.98
|
-11.32
|
-14.88
|
|
Peer Median
|
4.77
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
53.68
Higher than Peers by 32.41
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
53.68
|
47.33
|
18.04
|
18.21
|
37.42
|
|
Peer Median
|
21.27
|
--
|
--
|
--
|
--
|
Asset Turnover
0.18
Lower than Peers by 0.22
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
0.18
|
0.38
|
0.37
|
0.37
|
0.22
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
--
|
116.46
|
81.67
|
94.51
|
125.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
--
|
209.95
|
215.50
|
194.37
|
142.55
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
--
|
400.39
|
581.19
|
734.35
|
621.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
--
|
-73.97
|
-284.03
|
-445.47
|
-352.90
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
1.00
Lower than Peers by 36.32
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
1.00
|
19.20
|
-0.89
|
-0.39
|
-0.05
|
|
Peer Median
|
37.32
|
--
|
--
|
--
|
--
|
Price / Book Value
0.57
Lower than Peers by 7.18
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
0.57
|
2.62
|
1.80
|
1.04
|
0.10
|
|
Peer Median
|
7.75
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.29
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
-0.29
|
-6.24
|
-0.57
|
-0.20
|
0.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
92
Lower than Peers by 2,429
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fortress Biotech (FBIO)
|
92
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2,521
|
--
|
--
|
--
|
--
|